| Title |
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
|
|---|---|
| Published in |
Vascular Health and Risk Management, January 2013
|
| DOI | 10.2147/vhrm.s39300 |
| Pubmed ID | |
| Authors |
Valentina Lukashevich, Anja Schweizer, James E Foley, Sheila Dickinson, Per-Henrik Groop, Wolfgang Kothny |
| Abstract |
The purpose of this study was to evaluate the efficacy of vildagliptin 50 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate < 30 mL/min/1.73 m(2)) and longstanding type 2 diabetes not adequately controlled with insulin therapy, which is a difficult-to-treat population, with limited therapeutic options and a high susceptibility to hypoglycemia. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 88 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Finland | 1 | 1% |
| Denmark | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 85 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 24% |
| Student > Bachelor | 13 | 15% |
| Researcher | 10 | 11% |
| Other | 9 | 10% |
| Student > Ph. D. Student | 7 | 8% |
| Other | 11 | 13% |
| Unknown | 17 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 41% |
| Nursing and Health Professions | 11 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 9% |
| Agricultural and Biological Sciences | 3 | 3% |
| Biochemistry, Genetics and Molecular Biology | 3 | 3% |
| Other | 7 | 8% |
| Unknown | 20 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 February 2013.
All research outputs
#20,823,121
of 25,584,565 outputs
Outputs from Vascular Health and Risk Management
#663
of 785 outputs
Outputs of similar age
#229,887
of 289,948 outputs
Outputs of similar age from Vascular Health and Risk Management
#6
of 6 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 785 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,948 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.